SavedAdd your journal

Journals / Marmara Medical Journal / 2019 / Cilt: 32 - Sayı: 1

The relation between body mass index and end organ damage in white coat hypertension

Beyaz önlük hipertansiyonunda uç organ hasarı ile vücut kitle indeksi arasındaki ilişki

Atakan DEMİR
Mevlüt Tamer DİNÇER
Pages
50–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: White coat hypertension (WCH) is characterized by

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: White coat hypertension (WCH) is characterized by
📊
Key Findings & Data:Objective: White coat hypertension (WCH) is characterized by
💡
Conclusion & Impact:Objective: White coat hypertension (WCH) is characterized by
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hipertansiyon · Vücut Kitle İndeksi · Kan basıncı

Abstract

Objective: White coat hypertension (WCH) is characterized by

Özet

Amaç: Beyaz önlük hipertansiyonu (BÖH) poliklinik ölçümlerinde

🔖

Cite This Article

DEMİR, A., DİNÇER, M. T. (2019). The relation between body mass index and end organ damage in white coat hypertension. Marmara Medical Journal, Cilt: 32 - Sayı: 1, 50–54. https://ajindex.com/articles/284277

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease.Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990
  2. doi: 10.1016/0140-6736(90)90878-9 2. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000
  3. 320(7242):1128- 34. doi: 10.1136/bmj.320.7242.1128 3. Erdogan D, Caliskan M, Gullu H, et al. Aortic elastic properties and left ventricular diastolic function in white-coat hypertensive individuals. Blood Press Monit 2006
  4. doi: 10.1097/01.mbp.000.020.9079.17246.7d 4. Ihm SH, Youn HJ, Park CS, et al. Target organ status in white-coat hypertensives: usefulness of serum procollagen type I propeptide in the respect of left ventricular diastolic dysfunction. Circ J 2009
  5. doi: 10.1253/circj.CJ- 08-0464 5. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 2008
  6. doi: 10.1097/ HJH.0b013e3282f4b3bf 6. Pioli MR, Ritter AM, de Faria AP, Modolo R. White coat syndrome and its variations: differences and clinical impact. Integr Blood Press Control 2018
  7. doi:10.2147/IBPC. S152761 7. Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res 2017
  8. 1–7. doi: 10.1016/j.phrs.2017.05.013. 8. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014
  9. doi: 10.1001/jama.2013.284427 9. Wagener HP, Clay GE, Gipner JF. Classification of retinal lesions in the presence of vascular hypertension: Report submitted to the American Ophthalmological Society by the committee on Classification of Hypertensive Disease of the Retina. Trans Am Ophthalmol Soc 1947
  10. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/ AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018
  11. e13. doi: 10.1161/ HYP.000.000.0000000066 11. Julius S, Mejia A, Jones K, et al. “White coat” versu